Acute effects of peritoneovenous shunting on plasma atrial natriuretic peptide in cirrhotic patients with massive refractory ascites.

Campbell, P J; Skorecki, K L; Logan, A G; Wong, P Y; Leung, W M; Greig, P; Blendis, L M

Campbell, P J; Skorecki, K L; Logan, A G; Wong, P Y; Leung, W M; Greig, P; Blendis, L M.

Affiliation

Campbell PJ; Department of Medicine, Toronto General Hospital, University of Toronto, Ontario, Canada.

Am J Med ; 84(1): 112-9, 1988 Jan.

Article in En | MEDLINE | ID: mdl-2827465

Subject(s)

Atrial Natriuretic Factor/blood; Liver Cirrhosis/therapy; Peritoneovenous Shunt; Aged; Atrial Natriuretic Factor/physiology; Cyclic GMP/urine; Diet, Sodium-Restricted; Diuresis; Humans; Liver Cirrhosis/physiopathology; Middle Aged; Natriuresis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peritoneovenous Shunt / Atrial Natriuretic Factor / Liver Cirrhosis Limits: Aged / Humans / Middle aged Language: En Journal: Am J Med Year: 1988 Type: Article Affiliation country: Canada

Search on Google

XML

PubMed Links